CN1200282A - Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer - Google Patents

Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer Download PDF

Info

Publication number
CN1200282A
CN1200282A CN 97108082 CN97108082A CN1200282A CN 1200282 A CN1200282 A CN 1200282A CN 97108082 CN97108082 CN 97108082 CN 97108082 A CN97108082 A CN 97108082A CN 1200282 A CN1200282 A CN 1200282A
Authority
CN
China
Prior art keywords
radix
fructus
medicine
effect
preparata
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 97108082
Other languages
Chinese (zh)
Other versions
CN1062168C (en
Inventor
陈本洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97108082A priority Critical patent/CN1062168C/en
Publication of CN1200282A publication Critical patent/CN1200282A/en
Application granted granted Critical
Publication of CN1062168C publication Critical patent/CN1062168C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

A Chinese traditional medicine for eliminating the toxic side effect after chemotherapy to cancer patients is composed of 24 Chinese medical components which are decocted with water to obtain the invented medicine. Its advantages include abundant in raw material, simple in processing, low in cost and good in effect. Its effectual rate is 47%, effective rate is 53% and no effect rate is zero.

Description

The medicine of toxic and side effects in the cancer chemotherapy process is controlled in a kind of elimination
The present invention is a kind of Chinese medicine preparation that the cancer chemotherapy process is eliminated toxic and side effects that is used for controlling.
At present, the cancer patient who comes to seek medical advice, be mostly in, late period, except that lymph node under it is existing shift, the existing small cancer that shifts the elsewhere of Most patients also claims subclinical small cancer (Micrometastases).Operation, although be super-radical operation, or radiotherapy all can not solve the subclinical cancer problem that has shifted at a distance, must add with chemotherapy in 2~4 weeks after operation or the radiotherapy and solve this problem, to improve patient's survival rate at a specified future date.Yet chemotherapy although be combined chemotherapy, all has bigger toxic and side effects, and is particularly big to bone marrow depression and gastrointestinal reaction, often makes the patient not finish treatment plan smoothly, has a strong impact on therapeutic effect.For addressing this problem, have people's Western medicine such as " ZENGBAISU " or " SHENGBAINENG " once on probation keep the patient in chemotherapy process around the quantity of leucocyte of blood phase, to deal with defense function.But this class medicine is very expensive, general patient is difficult to bear, and this class medicine just stimulates storage blood pond release leukocyte to enter peripheral blood, when being badly in need of spending money from bank debits, get a bit just a little less, not the hemopoietic function of activated bone marrow, produce inexhaustible leukocyte etc. by the needs of body.When stopping using after " ZENGBAISU ", " SHENGBAINENG " combined with chemotherapy use a period of time, patient's integral status will be collapsed mutually with blood, causes the whole cancer One's cake is dough of controlling.
The objective of the invention is to: a kind of toxic and side effects that can eliminate in the cancer chemotherapy process is provided, strengthens patient's body constitution, low-cost Chinese medicine preparation---the warming and recuperating the spleen and kidney hemopoietic soup that is good for the stomach.Make the patient can cooperate the doctor to finish smelting treatment plan smoothly all the time, reach the purpose of curing cancer.
The object of the present invention is achieved like this: according to the theory of the traditional Chinese medical science " kidney governing bones; bone is given birth to marrow; the marrow promoting generation of vital essence and blood " and " the kidney being the origin of congenital constitution; the spleen being the foundation of acquired constitution ", select " warming and recuperating the spleen and kidney hemopoietic be good for the stomach soup " prescription of the kinds of traditional Chinese medicines composition that can safeguard bone marrow normal hematopoiesis function and gastrointestinal tract normal stool absorption function for use.
Prescription of the present invention and percentage by weight are:
Radix Astragali 8.3~11.6, Rhizoma dioscoreae 5~8.3, northern Fructus Lycii 1.7~5,
Radix Ginseng Rubra 3.3~5, Radix Rehmanniae Preparata 3.3~5, light Herba Cistanches 2.7~5,
The boy joins 3.3~5, Radix Rehmanniae 3.3~5, and Radix Morindae Officinalis 3.3~5,
Radix Angelicae Sinensis 3.3~6.6, Fructus Corni 3.3~5, Fructus Psoraleae 5~6.7,
Radix Polygoni Multiflori Preparata 5~8.3, Semen Cuscutae 3.3~5, Rhizoma Drynariae 3.3~5,
Arillus Longan 3.3~5, Herba Epimedii 3.3~5, Herba Ecliptae 3.3~5,
Rhizoma Atractylodis Macrocephalae (parched) 1.7~5, Radix Ophiopogonis 1.7~5, ripe Fructus Ligustri Lucidi 3.3~6.6,
Poria 3.3~5, Radix Asparagi 1.7~5, Radix Glycyrrhizae Preparata 1.7~3.3.
Advantage of the present invention: 1. the present invention all adopts Chinese herbal medicine, and raw material is extensive, and low price is easy to process, as long as use decocting 2~3 times, mixes the back and just can take; 2. can make the patient in the chemotherapy process of cancer, keep blood within normal range, leukopenia not occur,, after taking 5~7 days, can recover normal as the person that has the leukopenia originally; 3. can keep the patient normal, can not occur feeling sick, symptoms such as vomiting or abdominal pain diarrhea,, after taking 3~5 days, will recover normal, and keep vigorous appetite as the person that had the inappetence originally in chemotherapeutic period appetite; 4. the present invention also has the generally effect of enhancing body body constitution except the hemopoietic digestion promoting function is arranged, and strengthening the body resistance is arranged, the resistance against diseases of enhancing body.Facts have proved the patient after taking decoction of the present invention, body constitution has obvious enhancing, is difficult for secondary infection, and flu all is difficult for taking place.5. the present invention is applied widely, and it can simplify sanction with the different state of an illness and disease adding of filling a prescription, and makes it individuation or makes the preparation series of various cancers.There are sympotoms caused by cold factors persons such as abdomen pain, vomiting can add the Fructus Evodiae Tonga flavor of stomach warming cold expelling, promoting the circulation of QI to relieve pain, preventing or arresting vomiting as gastric cancer; If pulmonary carcinoma has cough, coughs up phlegm and with irregular heating paresthesia person, can add the baihe gujin decoction plus-minus, or adds nourishing YIN and clearing away lung-heat Tonga flavor; Subtract as then add the cooling blood for hemostasis Tonga of promoting the production of body fluid with spitting of blood person.If add relevant Chinese medicine medicine for preventing, better effects if then, can obviously shorten the course of treatment.
Introduce a most preferred embodiment below and implement after effect.
The composition and the percentage by weight thereof of most preferred embodiment are as follows:
Radix Astragali 10 Rhizoma dioscoreaes 6.7 northern Fructus Lyciis 3.3
Radix Ginseng Rubra 5 Radix Rehmanniae Preparata 5 light Herba Cistanches 3.3
The boy joins 5 Radix Rehmanniae, 5 Radix Morindae Officinaliss 4
Radix Angelicae Sinensis 5 Fructus Corni 4 Fructus Psoraleae 5.3
Radix Polygoni Multiflori Preparata 6.7 Semen Cuscutae 5 Rhizoma Drynariae 5
Arillus Longan 4 Herba Epimedii 4 Herba Ecliptaes 5
Rhizoma Atractylodis Macrocephalae (parched) ripe Fructus Ligustri Lucidi 54 Radix Ophiopogonis 3.3
Poria 4 Radix Asparagis 3.3 Radix Glycyrrhizae Preparatas 2
With above-mentioned Chinese medicine decocting secondary, extracting juice divides takes every day 2 times for 6 times.
Above-mentioned optimum formula, through the clinical use of 356 routine cancer patients: 1. the reaction result of matter is: that finishes the chemotherapy plan accounts for 30%, that does not finish the chemotherapy plan accounts for 70%, finish treatment plan in the middle of, survival had 7% more than 10 years, survive 5~10 years account for 33%, survive 2~5 years account for 50%, 1~2 years account for 10%.The reason of not finishing treatment plan has 3, and (1) is financial difficulties, and no money is cured; (2) be to deny oneself suffering from cancer, refusal continues treatment; (3) lump transference cure identifies oneself more to refuse to continue full treatment.2. use back grade result to be: that takes back effect produce effects accounts for 47%, effectively accounts for 53%, and invalid is 0.3. effectively reliability is more than 94% as calculated.

Claims (1)

1, the warming and recuperating the spleen and kidney hemopoietic soup that is good for the stomach is made up of kinds of traditional Chinese medicines, and when taking, behind decocting, the extracting juice part vic is characterized in that: the Chinese medicinal ingredients of this invention and percentage by weight thereof are:
Radix Astragali 8.3~11.6 Rhizoma dioscoreaes 5~8.3, northern Fructus Lycii 1.7~5,
Radix Ginseng Rubra 3.3~5, Radix Rehmanniae Preparata 3.3~5, light Herba Cistanches 2.7~5,
The boy joins 3.3~5, Radix Rehmanniae 3.3~5, and Radix Morindae Officinalis 3.3~5,
Radix Angelicae Sinensis 3.3~6.6, Fructus Corni 3.3~5, Fructus Psoraleae 5~6.7,
Radix Polygoni Multiflori Preparata 5~8.3, Semen Cuscutae 3.3~5, Rhizoma Drynariae 3.3~5,
Arillus Longan 3.3~5, Herba Epimedii 3.3~5, Herba Ecliptae 3.3~5,
Rhizoma Atractylodis Macrocephalae (parched) 1.7~5, Radix Ophiopogonis 1.7~5, ripe Fructus Ligustri Lucidi 3.3~6.6,
Poria 3.3~5, Radix Asparagi 1.7~5, Radix Glycyrrhizae Preparata 1.7~3.3.
CN97108082A 1997-05-26 1997-05-26 Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer Expired - Fee Related CN1062168C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97108082A CN1062168C (en) 1997-05-26 1997-05-26 Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97108082A CN1062168C (en) 1997-05-26 1997-05-26 Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer

Publications (2)

Publication Number Publication Date
CN1200282A true CN1200282A (en) 1998-12-02
CN1062168C CN1062168C (en) 2001-02-21

Family

ID=5170111

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97108082A Expired - Fee Related CN1062168C (en) 1997-05-26 1997-05-26 Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer

Country Status (1)

Country Link
CN (1) CN1062168C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199609B (en) * 2007-08-09 2010-10-06 贾立群 Chinese medicine for treating chemo-treatment medicament derived peripheral nerve toxicity
CN103330807A (en) * 2013-07-13 2013-10-02 石强 Natural drug composite, and preparation method and purpose thereof
CN104274759A (en) * 2014-09-19 2015-01-14 邓立华 Formula and preparation method of Chinese medicinal diet for nourishing after leukaemia chemotherapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1105588A (en) * 1994-11-02 1995-07-26 范冬锁 Anticancer traditional Chinese medicine "Bisikang" capsule and its preparation method

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101199609B (en) * 2007-08-09 2010-10-06 贾立群 Chinese medicine for treating chemo-treatment medicament derived peripheral nerve toxicity
CN103330807A (en) * 2013-07-13 2013-10-02 石强 Natural drug composite, and preparation method and purpose thereof
CN104274759A (en) * 2014-09-19 2015-01-14 邓立华 Formula and preparation method of Chinese medicinal diet for nourishing after leukaemia chemotherapy

Also Published As

Publication number Publication date
CN1062168C (en) 2001-02-21

Similar Documents

Publication Publication Date Title
CN102319407B (en) Traditional Chinese medicine for treating gastroptosis and extraction method thereof
CN102319408B (en) Chinese medicine for strengthening spleen, eliminating dampness and treating gastroptosis and extraction method thereof
CN1286518C (en) Chinese medicinal prescription for treating gastropathy
CN102357239B (en) Chinese medicine composition for treating chronic atrophic gastritis
CN1150933C (en) Chinese medicine for treating prostatitis, prostate hyperplasia and prostatauxe
CN101485803B (en) Chinese medicinal composition for treating menoxenia and dysmenorrhea
CN103893674A (en) Traditional Chinese medicinal pill for liver disease treatment and detoxification
CN101642523A (en) Chinese patent medicine for treating cardiovascular and cerebrovascular diseases
CN100998722B (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN1413629A (en) Oral liquid for nourishing yin and warming yang
CN101496873A (en) Medicament for treating chronic constipation
CN1062168C (en) Medicine for eliminating toxicity and side-effect casused by chemotherapy during treating cancer
CN103041200A (en) Traditional Chinese medicine composition for treating cerebral hemorrhage
CN105833179A (en) Traditional Chinese medicine for treating nonalcoholic steatohepatitis
CN102327572A (en) Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof
CN104524406A (en) Medicine for treating chronic gastritis
CN101675989A (en) Qi-supplementing, spleen-invigorating, kidney-tonifying and blood-generating traditional Chinese medicine composition
CN1101199C (en) Chinese-medicinal capsule for treating hyperlipomia
CN1061846C (en) Traditional Chinese medicine prescription for tonifying the kidney reinforcing the spleen and nourishing the blood and preparation process
CN1876109A (en) A medicinal liquor for treating female constipation in menstruation period and preparation method thereof
CN115554379B (en) Liver-softening and stasis-removing granule
CN102166303B (en) Chinese medicinal composition for treating chronic atrophic gastritis
CN100502938C (en) Chinese medicine for gynecological infertility
CN100998817A (en) Orally taken Chinese medicine for treating constitutional hypotension
CN1118295C (en) Chinese herb medicine composition with kidney-reinforcing and blood circulation-promoting functions

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee